A novel pulsed-field ablation system, with the Varipulse catheter and the Trupulse generator (Biosense Webster), appeared to treat patients with drug-refractory paroxysmal atrial fibrillation (AF) ...
The Company’s nsPFA™ System demonstrates the ability to provide cardiac ablation and mapping capabilities with a single catheter in preclinical studies The Company collaborated with CardioNXT to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results